Brian McNamee
Förmögenhet: 16 M $ per 2026-09-30
Förmögenhet: 16 M $ per 2026-09-30
Brian Anthony McNamee is Chairman at CSL Ltd. since 2018.
Holds the position of Chairman & Independent Non-executive Director at CSL Behring LLC.
Serves as Chairman of the Geoff Ogilvy Foundation since 2021.
Acts as Director at CSL Innovation Pty Ltd. Formerly Chief Executive Officer, Executive Director & MD at CSL Ltd. from 2012 to 2013.
Served as Chairman at Genesis Care Pty Ltd. from 2019 to 2022.
Was Director at Gen-Probe, Inc. during 2002 to 2007 and again from 2010 to 2011.
Held the role of Managing Director at Pacific Biotechnology Ltd. Served as Director at Peter Maccallum Cancer Foundation Ltd. Worked as General Manager-Faulding Product Divisions at FH Faulding & Co. Ltd. Was President at CSL Behring LLC.
Acted as Principal at Tarnagulla Ventures Pty Ltd. Completed undergraduate and doctorate degrees at the University of Melbourne, with the doctorate conferred in 1979.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
CSL LIMITED 0,03 % | 2026-08-21 | 128 061 ( 0,03 % ) | 16 M $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| ZENYTH THERAPEUTICS LIMITED | Direktör/Styrelseledamot | - |
| CSL LIMITED | Ordförande | 2018-10-17 |
Geoff Ogilvy Foundation | Ordförande | 2021-05-01 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Ordförande | - |
| Företag | Position | Slut |
|---|---|---|
Genesis Care Pty Ltd.
Genesis Care Pty Ltd. Hospital/Nursing ManagementHealth Services Provides cancer care services | Ordförande | 2022-06-01 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | President | 2013-07-01 |
| CSL LIMITED | President | 2013-07-01 |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets nucleic acid probe-based products for clinical diagnosis | Direktör/Styrelseledamot | 2007-05-31 |
Tarnagulla Ventures Pty Ltd.
Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures invests in companies located across the globe, primarily in Australia and the United States. The firm focuses on life science and healthcare sectors. It participates in seed and early stage capital requirements. | Privat kapitalinvesterare | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 11 |
|---|---|
CSL Innovation Pty Ltd.
CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
CSL Ltd.
CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets nucleic acid probe-based products for clinical diagnosis | Health Technology |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FH Faulding & Co. Ltd.
FH Faulding & Co. Ltd. Pharmaceuticals: MajorHealth Technology Produces and wholesales pharmaceutical, household and allied products | Health Technology |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
Pacific Biotechnology Ltd. | |
Genesis Care Pty Ltd.
Genesis Care Pty Ltd. Hospital/Nursing ManagementHealth Services Provides cancer care services | Health Services |
Peter Maccallum Cancer Foundation Ltd. | |
Tarnagulla Ventures Pty Ltd.
Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures invests in companies located across the globe, primarily in Australia and the United States. The firm focuses on life science and healthcare sectors. It participates in seed and early stage capital requirements. | Finance |
Geoff Ogilvy Foundation |
Välj din utgåva
All finansiell information anpassad till den nationella nivån